Therefore, we investigated the association of CCDC58 expression with 8 indicators of tumor heterogeneity in pan-cancer, including TMB, MATH, MSI, NEO, PURITY, PLOIDY, HRD, and LOH, to determine if CCDC58 was a predictor of immunotherapeutic responses. This evidence concerns the gene MIX23 and cancer.